1.6M Bypass Surgeries are performed each year in the US to treat inadequate blood flow, in dialysis access, vascular trauma and organ transplantations. Vascular anastomosis is a weak link in any bypass surgery. The success of the procedure hinges on how well the connection was made and how well the connection holds up.

The gold standard in all vascular anastamoses to this day remains hand suturing.
Hand suturing makes fashioning an anastomosis a complex and time-consuming step, completely dependent on the surgeon’s dexterity. Current techniques present critical surgical risks such as blockage, leakage or infections, and require long “bloodless time” (stopping blood flow while the procedure is performed).

QVCONN™ VASCULAR CONNECTING DEVICE, ENABLES A CONSISTENT, FAST AND EFFICACIOUS ANASTOMOSIS WITHOUT THE USE OF SUTURES, CLIPS OR STAPLERS

HOW IT WORKS

End-to-end anastomosis
End-to-side anastomosis

KEEP IT SIMPLE. SUTURELESS.

Reduce risk of occlusion

Reduce risk of occlusion

Prevent anastomosis leakage

Prevent anastomosis leakage

Reduce risk of infection

Reduce risk of infection

Decrease OR time

Decrease OR time

Reduce risk of vessel spasm

Reduces risk of vessel spasm

Enable consistent anastomoses

Enable consistent anastomoses

Reduce risk of post op blood clots

Reduce risk of post op blood clots

Easily adopted to current techniques

Easily adopted to current techniques

OUR TEAM

Zvi Nitzan | CEO

Mr. Nitzan is an electronic engineer with 30 years experience in research and developement of electronic systems and medical devices. During his career, he has invented an registered over 25 patents in the US.

Shay Kahana | VP R&D

Enterpreneur and medical device development engineer of 20 years.

Dr. Offer Galili | Medical Director

Surgeon, vascular surgery specialist and Director of the Vascular Surgery Unit at Hillel Yaffe Medical Center, Hadera

Tami Kfir | VP Strategy & Business Development

Expert in Technology Licensing, portfolio management and Incubators in the field of Life Science. Brings 20 years of senior management position including CEO at HBL Hadasit Bio Holdings; VP Licensing at Yissum; Venture Partner at Infinity Equity and over 11 years of experience as a director in Public and Private companies.

CONTACT US

Mediconntech – M.C.T. Ltd. | Caesarea, ISRAEL

Cell: +972-54-430-7273 | info@mediconntech.com